Skip to content
10-Q

Quarterly Report

BIO-TECHNE Corp TECH

0001558370-25-000689

← back to feed
Filed
Feb 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Feb 3, 2025 158.09M sh
Short Term Investments Q2 2025 · Dec 31, 2024 $0
Short Term Investments Q2 2025 · Jun 30, 2024 $1.07M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $177.55M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $151.79M
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.08B
Stockholders Equity Q2 2025 · Sep 30, 2024 $2.14B
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.07B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.96B
Stockholders Equity Q2 2025 · Sep 30, 2023 $2B
Stockholders Equity Q2 2025 · Jun 30, 2023 $1.97B
Current Liabilities Q2 2025 · Dec 31, 2024 $161.26M
Current Liabilities Q2 2025 · Jun 30, 2024 $159.38M
Current Assets Q2 2025 · Dec 31, 2024 $634.64M
Current Assets Q2 2025 · Jun 30, 2024 $617.42M
Total Assets Q2 2025 · Dec 31, 2024 $2.67B
Total Assets Q2 2025 · Jun 30, 2024 $2.7B
Shares Diluted Q2 2025 · Dec 31, 2023 160.06M sh
Shares Diluted Q2 2025 · Dec 31, 2023 161M sh
Stock Repurchased Q2 2025 · Dec 31, 2023 $80.04M
Dividends Paid Q2 2025 · Dec 31, 2023 $25.21M
Capex Q2 2025 · Dec 31, 2023 $28.46M
Operating Cash Flow Q2 2025 · Dec 31, 2023 $142.5M
Eps Diluted Q2 2025 · Dec 31, 2023 $0.17
Eps Diluted Q2 2025 · Dec 31, 2023 $0.49
Eps Basic Q2 2025 · Dec 31, 2023 $0.17
Eps Basic Q2 2025 · Dec 31, 2023 $0.50
Sga Expense Q2 2025 · Dec 31, 2023 $115.67M
Sga Expense Q2 2025 · Dec 31, 2023 $221M
Net Income Q2 2025 · Dec 31, 2023 $27.47M
Net Income Q2 2025 · Dec 31, 2023 $78.46M
Operating Income Q2 2025 · Dec 31, 2023 $38M
Operating Income Q2 2025 · Dec 31, 2023 $93.87M
Gross Profit Q2 2025 · Dec 31, 2023 $176.59M
Gross Profit Q2 2025 · Dec 31, 2023 $361.78M
Cost Of Revenue Q2 2025 · Dec 31, 2023 $96.01M
Cost Of Revenue Q2 2025 · Dec 31, 2023 $187.76M
Revenue Q2 2025 · Dec 31, 2023 $272.6M
Revenue Q2 2025 · Dec 31, 2023 $549.53M